Skip to main content

Stage 3 Lung Cancer

Cancer is uncontrolled growth of abnormal cells. Growth of abnormal cells in one or both lungs could be indicative of lung cancer. These abnormal cells have a tendency to grow but do not develop into healthy tissue of lungs. Research has shown that 87% of lung cancer is related to smoking. Risks are considerably reduced if the person quits smoking.

Extent to which cancer has spread is categorized as different stages. The stage depends upon the size of tumor and areas it has spread to. Doctors decide mode of treatment based on the stage of cancer.

Localized cancer in a particular part of lung is termed as Stage 1. If it has spread to the lymph nodes at the top of the lungs, it is termed as Stage 2. Cancer spreads to the chest walls during Stage 3. There is a possibility of cancer having spread to other parts of the body such as windpipe or heart, once it reaches Stage 3. Sometimes there can be fluid collection around the lungs that contain cancer cells.

Symptoms of lung cancer can vary from patient to patient. Common symptoms are continuous cough or formation of phlegm with signs of blood in it. More pronounced are symptoms such as a hoarse voice or difficulty in swallowing. Sometimes there is a swelling at the cancerous area.

Lung cancer can be treated in many ways such as surgery, radiotherapy or chemotherapy. Doctors determine treatment depending upon the stage cancer has reached. In initial stages, the patient can be treated by chemotherapy or radiotherapy. Usually surgery is recommended to remove malignant tumor found in stage 3-lung cancer. If this does not suffice, the doctors remove the lung to abate growth of cancer cells. Some patients are given a combination of treatments. Chemotherapy is administered before surgery for effective treatment.

It is very important to detect cancer in its earlier stages for effective treatment. As the cancer spreads, treatment becomes more complicated.

Popular posts from this blog

Lung cancer survival rate - Stage 2 lung cancer

When a person looks for a medical professional about the stage 2 lung cancer, one of the first questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured. The lung cancer survival rate is affected by several variables. One such variable is age. Younger people tend to have a greater chance of survival for people over 50. This is due to the strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties. The spread of malignant tumor is a very important factor in determining the survival of lung cancer exchange rate. The tumors may spread from the lung tissu...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...